Insider Buying: Meyer Robert J., Chimerix Inc. [CMRX] Director invested 11,400 shares

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Chimerix Inc. shares valued at $23,470 were purchased by Meyer Robert J. on May 19. At $2.06 per share, Meyer Robert J. acquired 11,400 shares. The insider’s holdings grew to 26,400 shares worth approximately $52536.0 following the completion of this transaction.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Also, MIDDLETON FRED A purchased 20,000 shares, netting a total of over 40,738 in proceeds. Following the buying of shares at $2.04 each, the insider now holds 20,000 shares.

Before that, Andriole Michael T. had added 15,000 shares to its account. In a trade valued at $25,635, the Chief Business Officer and CFO bought Chimerix Inc. shares for $1.71 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $0.42 million.

As published in their initiating research note from CapitalOne on September 07, 2022, Chimerix Inc. [CMRX] has been an Overweight and the price target has been revised to $7. This represents a 71.57% premium over Wednesday’s closing price. Analysts at Maxim Group started covering the stock with ‘”a Buy”‘ outlook in a report released in late April. Earlier on March 31, 2021, Wedbush initiated its rating. Their recommendation was “an Outperform” for CMRX stock.

Analyzing CMRX’s Price Performance

On Wednesday, Chimerix Inc. [NASDAQ: CMRX] rose 0.51% to $1.99. The stock’s lowest price that day was $1.90, but it reached a high of $2.03 in the same session. During the last five days, there has been a drop of approximately -8.29%. Over the course of the year, Chimerix Inc. shares have dropped approximately -69.05%. Shares of the company reached a 52-week high of $7.0200 on 01/04/22 and a 52-week low of $1.2700 on 06/16/22. A 50-day SMA is recorded $2.3002, while a 200-day SMA reached $3.9773. Nevertheless, trading volume fell to 1.42 million shares from 1.25 million shares the previous day.

Support And Resistance Levels for Chimerix Inc. (CMRX)

According to the 24-hour chart, there is a support level at 1.9167, which, if violated, would cause prices to drop to 1.8433. In the upper region, resistance lies at 2.0467. The next price resistance is at 2.1033. RSI (Relative Strength Index) is 40.00 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1745, which suggests the price will decrease in the coming days. Percent R is at 83.02%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Chimerix Inc. subject to short interest?

Stocks of Chimerix Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.22 million shares to 3.92 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.7 million shares. A jump of 5.61% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.93 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.93.

Which companies own the most shares of Chimerix Inc. (CMRX)?

According to Rubric Capital Management LP filings, the company currently owns 7,084,604 shares, which is about 8.09% of the total CMRX shares outstanding. The investor’s shares have appreciated by 2,284,604 from its previous 13-F filing of 4800000.0 shares. With the completion of the buy transaction, Suvretta Capital Management LLC’s stake is now worth $11,597,731. BlackRock Fund Advisors acquire a 6.29% interest valued at $11.38 million while The Vanguard Group, Inc. purchased a 29,867 stake. A total of 3,524,000 shares of Chimerix Inc. were bought by Armistice Capital LLC during the quarter, and -2,540,867 were sold by SSgA Funds Management, Inc. In its current portfolio, MSD Partners LP holds 2,000,000 shares valued at $4.4 million.


Please enter your comment!
Please enter your name here